Fructooligosaccharides decreased the ability of probiotic Escherichia coli Nissle 1917 to adhere to co-cultures of human intestinal cell lines

Journal of the Korean Society for Applied Biological Chemistry

Volumn 58, Issue 1, 2015, Pages 45-52

  Kim, J K ^a   Shin, E C ^b   Park, H G ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Gyeongsang National University   (South Korea)

^c Cornell University ^*  (United States)

Author keywords

Adhesion; Escherichia coli Nissle 1917; Fructooligosaccharide; Prebiotics; Probiotics

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI NISSLE 1917;

EID: 84923779352     PISSN: 17382203     EISSN: 2234344X     Source Type: Journal    
DOI: 10.1007/s13765-015-0002-5     Document Type: Article

References (37)

1. Aronson M, Medalia O, Schori L, Mirelman D, Sharon N, Ofek I (1979) Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-d-mannopyranoside. J Infect Dis 139:329–332
2. Beachey EH, Giampapa CS, Abraham SN (1988) Bacterial adherence. Adhesin receptor-mediated attachment of pathogenic bacteria to mucosal surfaces. Am Rev Respir Dis 138:S45–S48
3. Bickert T, Trujillo-Vargas CM, Duechs M, Wohlleben G, Polte T, Hansen G et al (2009) Probiotic Escherichia coli Nissle 1917 suppresses allergen-induced Th2 responses in the airways. Int Arch Allergy Immunol 149:219–230
4. Buddington KK, Donahoo JB, Buddington RK (2002) Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumor inducers. J Nutr 132:472–477
5. Coudray C, Tressol JC, Gueux E, Rayssiguier Y (2003) Effects of inulin-type fructans of different chain length and type of branching on intestinal absorption and balance of calcium and magnesium in rats. Eur J Nutr 42:91–98
6. Dunne C, O’Mahony L, Murphy L, Thornton G, Morrissey D, O’Halloran S et al (2001) In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 73:386S–392S
7. Firon N, Ashkenazi S, Mirelman D, Ofek I, Sharon N (1987) Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells. Infect Immun 55:472–476
8. Flock JI (1999) Extracellular-matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections. Mol Med Today 5:532–537
9. Forstner JF, Forstner GG (1994) Gastrointestinal mucus. In: Johnson LR (ed) Physiology of the gastrointestinal tract, 3rd edn. Raven Press, New York, pp 1255–1283
10. Gibson GR (1999) Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J Nutr 129:1438S–1441S
11. Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125:1401–1412
12. Gibson GR, Wang X (1994) Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture. FEMS Microbiol Lett 118:121–127
13. Kamada N, Maeda K, Inoue N, Hisamatsu T, Okamoto S, Hong KS et al (2008) Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells. Infect Immun 76:214–220
14. Kim JK, Choi SJ, Cho HY, Kim YJ, Lim ST, Kim CJ et al (2010) Ipomoea batatas attenuates amyloid beta peptide-induced neurotoxicity in ICR mice. J Med Food 14:304–309
15. Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, Kascak M et al (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53:1617–1623
16. Laparra JM, Sanz Y (2009) Comparison of in vitro models to study bacterial adhesion to the intestinal epithelium. Lett Appl Microbiol 49:695–701
17. Lodinova-Zadnikova R, Sonnenborn U (1997) Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants. Biol Neonate 71:224–232
18. Mahler GJ, Shuler ML, Glahn RP (2009) Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability. J Nutr Biochem 20:494–502
19. McBain AJ, Macfarlane GT (1997) Investigations of bifidobacterial ecology and oligosaccharide metabolism in a three-stage compound continuous culture system. Scand J Gastroenterol Suppl 222:32–40
20. Michel C, Kravtchenko TP, David A, Gueneau S, Kozlowski F, Cherbut C (1998) In vitro prebiotic effects of Acacia gums onto the human intestinal microbiota depends on both botanical origin and environmental pH. Anaerobe 4:257–266
21. Mugambi MN, Musekiwa A, Lombard M, Young T, Blaauw R (2012) Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review. Nutr J 11:81
22. Navarro G, Cheng AT, Peach KC, Bray WM, Bernan VS, Yildiz FH et al (2013) Image-based 384-well high-throughput screening method for the discovery of skyllamycins A to C as biofilm inhibitors and inducers of biofilm detachment in Pseudomonasaeruginosa. Antimicrob Agents Chemother 58:1092–1099
23. Oelschlaeger TA (2010) Mechanisms of probiotic actions—a review. Int J Med Microbiol 300:57–62
24. Oku T (1996) Oligosaccharides with beneficial health effects: a Japanese perspective. Nutr Rev 54:S59–S66
25. Reissbrodt R, Hammes WP, dal Bello F, Prager R, Fruth A, Hantke K et al (2009) Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli. FEMS Microbiol Lett 290:62–69
26. Roberfroid MB, Delzenne NM (1998) Dietary fructans. Annu Rev Nutr 18:117–143
27. Roberfroid MB, Van Loo JA, Gibson GR (1998) The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 128:11–19
28. Rumessen JJ, Gudmand-Hoyer E (1998) Fructans of chicory: intestinal transport and fermentation of different chain lengths and relation to fructose and sorbitol malabsorption. Am J Clin Nutr 68:357–364
29. Sanchez B, Bressollier P, Urdaci MC (2008) Exported proteins in probiotic bacteria: adhesion to intestinal surfaces, host immunomodulation and molecular cross-talking with the host. FEMS Immunol Med Microbiol 54:1–17
30. Saulnier DM, Spinler JK, Gibson GR, Versalovic J (2009) Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr Opin Biotechnol 20:135–141
31. Schroeder B, Duncker S, Barth S, Bauerfeind R, Gruber AD, Deppenmeier S et al (2006) Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection. Dig Dis Sci 51:724–731
32. Schultz M, Strauch UG, Linde HJ, Watzl S, Obermeier F, Gottl C et al (2004) Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clin Diagn Lab Immunol 11:372–378
33. Simons K, Fuller SD (1985) Cell surface polarity in epithelia. Annu Rev Cell Biol 1:243–288
34. Tiihonen K, Ouwehand AC, Rautonen N (2010) Human intestinal microbiota and healthy ageing. Ageing Res Rev 9:107–116
35. Tzortzis G, Goulas AK, Gee JM, Gibson GR (2005) A novel galactooligosaccharide mixture increases the bifidobacterial population numbers in a continuous in vitro fermentation system and in the proximal colonic contents of pigs in vivo. J Nutr 135:1726–1731
36. Van Loo J, Cummings J, Delzenne N, Englyst H, Franck A, Hopkins M et al (1999) Functional food properties of non-digestible oligosaccharides: a consensus report from the ENDO project (DGXII AIRII-CT94-1095). Br J Nutr 81:121–132
37. Wang X, Gibson GR (1993) Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 75:373–380